About UltraSight
UltraSight is a digital health pioneer transforming cardiac imaging through the power of artificial intelligence. The company's real-time AI guidance software enables medical professionals without sonography experience to acquire diagnostic-quality cardiac ultrasound images across multiple care settings, including emergency departments, clinics, community hospitals, ambulances, and remote areas. The platform pairs with point-of-care ultrasound devices and provides a graphic interface overlaid on the ultrasound screen, guiding users in real-time on how to maneuver the probe to obtain diagnostic quality images. UltraSight's technology addresses a critical healthcare gap: while over 8 million patients are admitted to U.S. emergency departments annually with symptoms concerning for heart attack or heart failure, and approximately 30 million heart disease patients require periodic cardiac monitoring, significant bottlenecks and limited training resources restrict access to timely cardiac ultrasound. The company's AI neural network predicts the position of the ultrasound probe relative to the heart based on the ultrasound video stream, providing three-dimensional guidance with precise magnitude of movement. Clinical studies demonstrate that after minimal training with the AI guidance software, novice users can acquire images of diagnostic quality approaching that of expert sonographers in 93-100% of patient exams. UltraSight has received FDA clearance and CE Marking, enabling deployment across healthcare systems, emergency medicine, out-of-hospital care, and critical care settings.
Mission & Story
Mission
Our goal is to make diagnostic imaging more accessible by empowering medical professionals to successfully acquire timely and accurate cardiac ultrasound images anywhere.
Founding Story
The company was founded to address the significant disproportion between the number of heart disease patients and availability of cardiac ultrasound. The founding team applied deep geometrical machine-learning techniques to cardiac ultrasound to close the skillset gap and empower medical professionals to acquire accurate cardiac images anywhere. Previously known as OnSight Medical, the company changed its name to UltraSight.
Clinical Focus
Medical conditions and clinical areas addressed by UltraSight.
Who It Serves
Milestones & Awards
Recent Milestones
FDA clearance granted July 2023. Expanded FDA clearance received to work across ultrasound systems. New data presented at ACC 2025 and THT 2026. PVAD IQ product for critical care launched. Seeking clinical researchers for investigator-led research grants.
Awards & Recognition
Won TCT 2020 Innovation Competition at Transcatheter Cardiovascular Therapeutics conference. Won Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge in 2022 as most innovative cardiac technology. Awarded patent for real-time guidance solution for ultrasound devices.
Key Partnerships
Social & Media
Follow on
Latest Updates
New Data at ACC.26 Demonstrating UltraSight® AI Enables Non-Experts to Perform Diagnostic Cardiac Ultrasound
UltraSight Advances AI-Enabled Workflows in Cardiac Critical Care
UltraSight® PVAD IQ Achieves Expert-Level Accuracy, Data Presented as Late-Breaking at THT 2026
Stanford RCT Validates UltraSight: Faster Scans, Better Imaging Quality, and Scalable Training
UltraSight Receives KFDA Regulatory Approval for AI Guidance System, Expanding Global Access to Cardiac Imaging
Company Details
- Headquarters
- Cambridge, MA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.